FDA Inspection 767444 — Adare Pharmaceuticals, Inc.

Adare Pharmaceuticals, Inc. — FEI 1525864

The FDA completed an inspection of Adare Pharmaceuticals, Inc. on December 21, 2011 in Vandalia, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 21, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vandalia, OH (United States)